Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Epstein

Showing results (1061-1070 of 1,132) with videos related to

Pageof 114
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2013
Rb loss is characteristic of prostatic small cell neuroendocrine carcinomaHsueh-Li Tan, Akshay Sood, Hameed A Rahimi, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 4, 2020
Adverse histology, homozygous loss of CDKN2A/B, and complex genomic alterations in locally advanced/metastatic renal mucinous tubular and spindle cell carcinomaChen Yang, Robert S Cimera, Ruth Aryeequaye, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 12, 2011
Increased gene copy number of ERG on chromosome 21 but not TMPRSS2-ERG fusion predicts outcome in prostatic adenocarcinomasAntoun Toubaji, Roula Albadine, Alan K Meeker, et al.
The Journal of Pathology|October 31, 2006
Genomic aberrations are rare in urothelial neoplasms of patients 19 years or youngerP J Wild, J Giedl, R Stoehr, et al.
The Journal of Urology|February 7, 2001
Effects of a saw palmetto herbal blend in men with symptomatic benign prostatic hyperplasiaL S Marks, A W Partin, J I Epstein, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie|September 18, 2007
[Urothelial neoplasms in individuals younger than 20 years show very few genetic alterations and have a favourable clinical outcome]Johannes Giedl, Peter J Wild, Robert Stoehr, et al.
Urologiia (Moscow, Russia : 1999)|July 30, 2019
[The experience of using drug Afalaza for treatment of lower urinary symptoms in treatment-nave patients with benign prostatic hyperplasia]Yu A Kupriyanov, P I Rasner, I M Rokhlikov, et al.
Bulletin of Experimental Biology and Medicine|June 11, 2009
Study of efficiency of therapeutic and preventive anaferon (pediatric formulation) in mice with influenza infectionL N Shishkina, A N Sergeev, A S Kabanov, et al.
The Prostate|May 13, 2009
Individual and cumulative effect of prostate cancer risk-associated variants on clinicopathologic variables in 5,895 prostate cancer patientsA Karim Kader, Jielin Sun, Sarah D Isaacs, et al.
Histopathology|October 10, 2013
An interobserver reproducibility study on invasiveness of bladder cancer using virtual microscopy and heatmapsEva Compérat, Lars Egevad, Antonio Lopez-Beltran, et al.
Pageof 114

Showing results (1061-1070 of 1,132) with videos related to

Sort By:
Pageof 114
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2013
Rb loss is characteristic of prostatic small cell neuroendocrine carcinomaHsueh-Li Tan, Akshay Sood, Hameed A Rahimi, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 4, 2020
Adverse histology, homozygous loss of CDKN2A/B, and complex genomic alterations in locally advanced/metastatic renal mucinous tubular and spindle cell carcinomaChen Yang, Robert S Cimera, Ruth Aryeequaye, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 12, 2011
Increased gene copy number of ERG on chromosome 21 but not TMPRSS2-ERG fusion predicts outcome in prostatic adenocarcinomasAntoun Toubaji, Roula Albadine, Alan K Meeker, et al.
The Journal of Pathology|October 31, 2006
Genomic aberrations are rare in urothelial neoplasms of patients 19 years or youngerP J Wild, J Giedl, R Stoehr, et al.
The Journal of Urology|February 7, 2001
Effects of a saw palmetto herbal blend in men with symptomatic benign prostatic hyperplasiaL S Marks, A W Partin, J I Epstein, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie|September 18, 2007
[Urothelial neoplasms in individuals younger than 20 years show very few genetic alterations and have a favourable clinical outcome]Johannes Giedl, Peter J Wild, Robert Stoehr, et al.
Urologiia (Moscow, Russia : 1999)|July 30, 2019
[The experience of using drug Afalaza for treatment of lower urinary symptoms in treatment-nave patients with benign prostatic hyperplasia]Yu A Kupriyanov, P I Rasner, I M Rokhlikov, et al.
Bulletin of Experimental Biology and Medicine|June 11, 2009
Study of efficiency of therapeutic and preventive anaferon (pediatric formulation) in mice with influenza infectionL N Shishkina, A N Sergeev, A S Kabanov, et al.
The Prostate|May 13, 2009
Individual and cumulative effect of prostate cancer risk-associated variants on clinicopathologic variables in 5,895 prostate cancer patientsA Karim Kader, Jielin Sun, Sarah D Isaacs, et al.
Histopathology|October 10, 2013
An interobserver reproducibility study on invasiveness of bladder cancer using virtual microscopy and heatmapsEva Compérat, Lars Egevad, Antonio Lopez-Beltran, et al.
Pageof 114